KAZIA THERAPEUTICS LTD - SCHEDULE 13G/A Filing
2026-03-30SEC Filing SCHEDULE 13G/A (0001213900-26-036664)
This Schedule 13G/A filing pertains to KAZIA THERAPEUTICS LTD and reports on the ownership of American Depository Shares. The filing is made by Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar, collectively referred to as the "Reporting Persons". As of January 30, 2026, the Reporting Persons collectively beneficially owned 0% of the outstanding shares, indicating that this filing serves as an exit filing. The Reporting Persons have confirmed that the securities were not acquired or held for the purpose of influencing the control of the issuer. The filing includes an agreement of joint filing signed by Ashkan Mapar on behalf of all reporting entities.
Related industry:Biotechnology
Source:Original SEC Document β